Dr. Gottlieb, M.D., served as the FDA Commissioner from May 11, 2017 through April 5, 2019. In his short term as Commissioner he limited proliferation of e-cigarettes and led response to the opioid crisis in the US.
He also led major changes in modernizing FDA policies and processes for the 510 (k) device clearance including record number of generic drugs approval and digital health tools.
The United States Commissioner of Food and Drugs is the head of the Food and Drug Administration, an agency of the United States Department of Health and Human Services.
The commissioner is appointed by the president of the United States with the advice and consent of the Senate. The commissioner reports to the Secretary of Health and Human Services.